Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Endoscopic Ultrasound
100%
Abdominal Cancer
69%
Neoplasm
56%
Gastrointestinal Stromal Tumor
51%
Helicobacter Pylori
45%
Pancreas Cancer
44%
Chemotherapy
40%
Fine-Needle Aspiration
39%
Endoscopy
39%
Malignant Neoplasm
38%
Narrow Band Imaging
38%
Hepatocellular Carcinoma
35%
Diseases
32%
Endoscopic Submucosal Dissection
29%
Endoscopic Ultrasound Guided Fine Needle Biopsy
29%
Overall Survival
26%
Tumor
25%
Stomach
24%
Cancer
23%
Pancreas Disease
19%
Stomach Mucosa
19%
Chronic Pancreatitis
19%
Autoimmune Pancreatitis
18%
Pancreas Adenocarcinoma
18%
Ulcerative Colitis
18%
Oral
18%
Echography
18%
Polyp
18%
Biliary Tract Drainage
18%
Computer Assisted Tomography
17%
Imatinib
16%
Confocal Laser Scanning Microscopy
15%
Bevacizumab
15%
Atezolizumab
15%
Choledochoduodenostomy
14%
Stenosis
14%
Upper Digestive Tract
14%
Ulcer
14%
Colonoscopy
14%
Pancreas Tumor
13%
Mucosa
13%
Steroid
13%
Multivariate Analysis
13%
Hazard Ratio
13%
Progression Free Survival
13%
Differential Diagnosis
13%
Biopsy Technique
12%
Bleeding
12%
Odds Ratio
12%
Liver Function
11%
Magnifying Endoscopy
11%
Immunoglobulin G4
11%
Colon
11%
Intraductal Papillary Mucinous Tumor
11%
Gut Microbiota
11%
Adenoma
10%
Pancreatic Duct
10%
Cholestasis
9%
Biological Marker
9%
Lymphocyte
9%
Inflammatory Bowel Disease
9%
White Light Endoscopy
9%
Scoring System
9%
Ras Signaling
9%
Gallbladder Cancer
9%
Adverse Event
9%
Clinical Study
8%
Double-Balloon Enteroscopy
8%
Steroid Treatment
8%
Oncology
8%
Esophagus
8%
Recurrent Disease
8%
Patient with Ulcerative Colitis
8%
Colorectal Tumor
8%
Hematemesis
8%
Anemia
8%
Duodenum
8%
CpG Island
8%
Sclerosing Cholangitis
8%
Diagnostic Accuracy
8%
Placebo
7%
Progressive Disease
7%
Adjuvant Chemotherapy
7%
Charlson Comorbidity Index
7%
Post-Hoc Analysis
7%
Pancreatitis
7%
Observational Study
7%
Helicobacter Infection
7%
Lymphatic Follicle
7%
Macrogol
7%
Adoptive Immunotherapy
7%
Zoledronic Acid
7%
Killer Cell
7%
Jejunum Ulcer
7%
Esophageal Cancer
7%
DNA Methylation
7%
MALT Lymphoma
7%
Tumor Necrosis Factor
7%
Biliary Tract Disease
7%
COVID-19
7%
Keyphrases
Gastric Cancer
57%
Gastrointestinal Stromal Tumor
37%
Japan
36%
Helicobacter Pylori Eradication
34%
Atezolizumab
31%
Advanced Hepatocellular Carcinoma
30%
Ulcerative Colitis
29%
Gastric Cancer Patients
29%
Gastric mucosa
26%
Endoscopic Ultrasound-guided Fine-needle Aspiration (EUS-FNA)
26%
Pancreatic Cancer
24%
95% Confidence Interval
23%
Tumor
23%
Endoscopic Submucosal Dissection
23%
Overall Survival
22%
Polymorphism
22%
Clinical Outcomes
20%
MicroRNA
20%
Advanced Gastric Cancer
20%
Phase I Study
19%
Endoscopic Ultrasonography
19%
Endoscopic Ultrasound
19%
Stomach
19%
Helicobacter Pylori (H. pylori)
19%
Chemotherapy
19%
Colorectal Tumor
18%
Japanese Patients
18%
Gut Microbiota
18%
Chronic Pancreatitis
18%
Methylation Status
17%
Endoscopic Features
17%
Magnifying Narrow-band Imaging
15%
Non-neoplastic
14%
Autoimmune Pancreatitis
14%
Upper Gastrointestinal Tract
14%
Mucosa
14%
Early Gastric Cancer
14%
Hepatocellular Carcinoma
14%
CpG Island Methylation
13%
Crohn's Disease
13%
Pancreatic Diseases
13%
Progression-free Survival
13%
Promoter Methylation
13%
Genetic Polymorphism
13%
Pancreatic Ductal Adenocarcinoma
13%
Odds Ratio
13%
Liver Function
12%
DNA Methylation (DNAm)
12%
Genotype
12%
Endoscopic Ultrasound-guided
12%
Nationwide Survey
12%
Interleukin-1β
11%
Small Intestine
11%
Methylation
11%
CpG Island Methylator Phenotype
11%
Adverse Events
11%
Survey in Japan
11%
Capecitabine
11%
Clinical Phenotype
11%
Helicobacter Pylori Infection
10%
Lenvatinib
10%
Multivariate Analysis
10%
Malignancy
10%
Gallbladder Cancer
10%
Risk Factors
10%
Ulcer
10%
Hazard Ratio
9%
Methylenetetrahydrofolate Reductase (MTHFR)
9%
Inflammatory Bowel Disease
9%
Colorectal Cancer
9%
Differential Diagnosis
9%
5-fluorouracil (5-FU)
9%
Colonic mucosa
9%
Computed Tomography
9%
Pancreatic Tumor
9%
Gene Polymorphism
8%
Bevacizumab
8%
Bevacizumab Therapy
8%
Histopathological Diagnosis
8%
Esophagus
8%
Disease Control
8%
Alpha-fetoprotein
8%
Progressive Disease
8%
S-1 Monotherapy
8%
Gastrointestinal Tract
8%
Cisplatin
8%
Pancreatic Neuroendocrine Tumors (pNETs)
7%
MiR-124
7%
Previously Treated
7%
Toga
7%
MiR-143
7%
Complete Response
7%
Treatment Lines
7%
Bleeding
7%
Prognosis Prediction
7%
Gastric Carcinoma
7%
White Light Endoscopy
7%
Endoscopic Findings
7%
Partial Response
7%
Pre-microRNA
7%